Page 21 - Bharat Biotech

Bharat Biotech concludes recruitment for Covaxin's phase 3 study

Bharat Biotech has concluded the recruitment of volunteers for the phase III trials of its Covid vaccine, Covaxin, on Thursday after achieving the sample size it had promised to the ethics committee

Bharat Biotech vaccine may cost less than Serum's; govt working on pricing

The final contract is expected to be signed soon

Is India ready for vaccine rollout? Key Covid updates of the last 24 hours

The health ministry is prepared to roll out the Covid vaccine within 10 days of the emergency use authorisation, which was granted to two companies on January 3

70 mn doses ready: Delays over pricing holding back India's vaccine rollout

The Indian government may be looking to put pressure on Serum to lower its prices, as seen by its controversial decision to greenlight a rival vaccine

Next big bet: Experts bullish on Bharat Biotech's upcoming nasal vaccine

Bharat Biotech is currently working on two intra-nasal vaccines

Govt ready to roll out vaccine within 10 days of emergency nod: Health secy

Health personnel succh as doctors and nurses and frontline workers such as police personnel, home guards won't have to register themselves online to get the vaccine

Vaccine firms Bharat Biotech, Serum Institute patch up after war of words

Adar Poonawalla and Krishna Ella issue joint statement saying they would work together to roll out Covid-19 vaccine

Govt clears air on Bharat Biotech's vaccine, says relied on safety data

Minutes of expert panel meeting made public

Top headlines: India aims to double gas pipeline; SC clears Central Vista

A FinMin report says India is witnessing a 'V-shaped' economic recovery since June; China court awards death sentence to former business executive.

Serum, Bharat Biotech announce 'combined intent' to supply vaccines

The more important task right now is of saving the lives and livelihoods of populations in India and around the world, a joint statement by both companies said

India Coronavirus Dispatch: Nod to Covaxin raises many eyebrows

Other vaccines being developed in India, dangerous conspiracy theories, private hospitals keen on jumping in-news relevant to India's fight against Covid-19

India's Covid-19 vaccination challenge needs a private sector helping hand

The media and opposition figures have justifiably asked why Bharat Biotech's candidate was approved at the same time as AstraZeneca's, when it hasn't even finished or published results from Stage III

Best of BS Opinion: Covid-19 vaccine, promise of techno-nationalism & more

Here's a selection of Business Standard opinion pieces for the day

Covid-19 vaccine: I am not worried about the efficacy, says Jacob John

I would go for Bharat Biotech's Covaxin and not Covishield, and that is my personal judgment, the former head of Centre for Advanced Research in Virology at ICMR says

Bharat Biotech chief takes on Serum Institute in Covid-19 vaccine war

Krishna Ella turns the tables on critics, questions approval granted to Oxford-Astra vaccine

A shot at transparency

Approval to Covaxin raises many questions

Covaxin: Science, not pride will help India build trust in this vaccine

The hasty nod for Bharat Biotech's Covaxin, developed in collaboration with the ICMR and National Institute of Virology, has raised eyebrows in the scientific and healthcare communities

World's biggest Covid-19 vaccination programme set to begin in India: PM

Lauding the people behind this Made in India initiative, Modi said: "The country is proud of the contributions of its scientists and technicians."

Bharat Biotech aims to make 700 million doses of Covid-19 vaccine in 2021

The vaccine candidate, Covaxin, received emergency use approval from India's drugs regulator on Sunday

Bharat Biotech hits outs at critics, says carried out '200% honest' trials

Questions were raised by industry experts and opposition parties on the emergency approval to its coronavirus vaccine without publication of efficacy data